Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam
Sponsor: Carl Zeiss Meditec, Inc.
This observational or N/A phase trial investigates Cornea and is currently completed. Carl Zeiss Meditec, Inc. leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2020 [monthly]
Completed
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Carl Zeiss Meditec, Inc.
- ClinReg Consulting Services, Inc.
- Sierra Clinical Services, LLC
For direct contact, visit the study record on ClinicalTrials.gov .